Evidence map›Paper›PMID 42324797›Full record

ReviewJournal of food science2026

Summary of the Safety Assessment Data of the Most Common Organogermanium Food Ingredient, Asaigermanium (Poly-trans-[(2-carboxyethyl)germasesquioxane]).

Sota Doiyama, Takashi Nakamura

Abstract readReview
In one paragraph

Review in Journal of food science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Sota DoiyamaAsai Germanium Research Institute Co., Ltd., Kawasaki, Kanagawa, Japan.ORCID https://orcid.org/0000-0003-4498-6177
Takashi NakamuraHakodate R&D Center of Asai Germanium Research Institute Co., Ltd., Hakodate, Hokkaido, Japan.ORCID https://orcid.org/0000-0003-4625-9416

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Asaigermanium is a water-soluble organogermanium compound created by Kazuhiko Asai and colleagues in 1967. It was first researched and developed decades ago as a pharmaceutical product, but it is now used as a raw material for food supplements and cosmetics. After more than 50 years of research and development, the physiological activities of Asaigermanium have been investigated, and the effects of Asaigermanium have been evaluated in multiple toxicological studies. However, because of the health hazards of inorganic germanium (germanium dioxide and lactic acid/citric acid-germanium, also known as the germanium-citrate-lactate complex), there have been false reports that all organogermanium compounds may be as harmful to health as inorganic germanium is. Therefore, in this review, in addition to providing an outline of the test data that have verified the safety of Asaigermanium thus far, we introduce the results from many recent toxicological studies. In addition, we describe the registered certification of Asaigermanium in the In-House Safety Association of Health Foods of the Japan Health and Nutrition Food Association, which is a third-party registration framework for the voluntary safety inspection of health food ingredients in Japan.

Indexed as

Food IngredientsFood SafetyGermaniumAnimalsHumansJapanFood IngredientsGermanium

Identifiers

PMID42324797
PMCPMC13284525

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.